Osaic Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Osaic Holdings's REGN Position: Q1 2026 in Review
Osaic Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 3.7% in Q1 2026, buying an estimated $336K and bringing the position to 12,238 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #954.
Osaic Holdings first reported a position in REGN in Q1 2020 and has held it in 25 quarters since. The position peaked at $14.9M in Q3 2023. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Osaic Holdings held 12,238 shares of Regeneron Pharmaceuticals worth $9.46M as of Q1 2026.
- Osaic Holdings bought 439 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $336K.
- Regeneron Pharmaceuticals made up 0.01% of Osaic Holdings's portfolio in Q1 2026, its #954 holding.
- Osaic Holdings first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Regeneron Pharmaceuticals position peaked at $14.9M in Q3 2023.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.